Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Report

Reports

Displaying 1 - 10 of 139. 10 per page. Page 1.

Advanced Search
Report

Network Adequacy for Behavioral Health: Existing Standards and Considerations for Designing Standards

November 22, 2021
Network adequacy is often defined as having enough providers within a health plan network to ensure reasonable and timely access to care. At a minimum, health plans should include a sufficient number of providers who deliver mental health and substance use disorder (SUD) services (collectively referred to in this report as behavioral health services) to support access to those services.
Report

Comparing Outcomes for Dual Eligible Beneficiaries in Integrated Care: Final Report

October 22, 2021
Dual eligible beneficiaries are an important subset of the Medicare and Medicaid populations because they have a high prevalence of chronic conditions and disabilities, substantial care needs, and high health care and long-term services and supports (LTSS) utilization and costs.
Report

Improving Outcomes for American Indian/Alaska Native People Returning to the Community from Incarceration: A Resource Guide for Service Providers

October 20, 2021
This resource guide for providers working with American Indian/Alaska Native people reentering their communities from incarceration, contains a compilation of federal resources, research, examples, and helpful considerations for facilitating a successful reentry. Related Products:
Report

Addressing Uncertainty in Regulatory Impact Analysis

October 15, 2021
In 2016, the U.S. Department of Health and Human Services finalized its Guidelines for Regulatory Impact Analysis under the leadership of its Assistant Secretary for Planning Evaluation and Analytics Team. The Guidelines discuss strategies for characterizing the uncertainty in quantified effects as well as the potential impacts of non-quantified effects.
Report

Prescription Drug Supply Chains: An Overview of Stakeholders and Relationships

October 14, 2021
Many stakeholders and steps are involved in the life cycle of a prescription drug as it moves from chemical synthesis and formulation through dispensing or administration to patients. The specific steps involved in prescription drug supply chains often differ depending on the type of drug, the channel of distribution, and the patient’s source of prescription drug coverage.
Report

Medical Device Supply Chains: An Overview and Description of Challenges During the COVID-19 Pandemic

October 13, 2021
This report provides an introduction to the supply chain for COVID-19 relevant medical devices and related challenges faced in ramping up their production during the COVID-19 pandemic.
Report

Assessing Relationships between Drug Shortages in the United States and Other Countries

October 13, 2021
Drug shortages are a persistent public health problem in the United States and in other countries. Shortages can have important implications for the health care systems and pharmacies that purchase, store, and dispense drugs and for the patients who rely on the availability of drugs to treat and prevent disease.
Report

Considerations for Building Federal Data Capacity for Patient-Centered Outcomes Research Related to Intellectual and Developmental Disabilities

October 13, 2021
This report describes the current state of Patient-Centered Outcomes Research (PCOR) data infrastructure resources related to Intellectual and Developmental Disabilities (ID/DD), highlights data issues in the ID/DD research landscape that require more research, and identifies opportunities to enhance data infrastructure to improve PCOR for ID/DD. Related Products:
Report

Guidelines for Regulatory Impact Analysis Supplement: Addressing International Effects

October 1, 2021
This report extends the brief discussion of addressing international effects contained in the Department of Health and Human Service Guidelines for Regulatory Impact Analysis (2016). The purpose of this supplement is to expand that discussion and provide more detailed information on conducting such assessments. Related Products:
Report

Federal Data for Conducting Patient-Centered Outcomes Research on Economic Outcomes

September 29, 2021
The objective of this report is to assess the current landscape of federal and federally funded health care data relevant to PCOR and economic analysis to identify gaps for data stewards, researchers, and future collection efforts.